GEORGE CARRUM

Concepts (331)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
32
2024
1190
2.610
Why?
Graft vs Host Disease
15
2024
622
1.320
Why?
Hodgkin Disease
8
2022
298
1.180
Why?
T-Lymphocytes
16
2024
1805
1.100
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
7
2016
177
0.890
Why?
Salvage Therapy
3
2021
202
0.860
Why?
Lymphoma
4
2021
333
0.770
Why?
Antigens, Neoplasm
5
2021
407
0.720
Why?
Transplantation, Autologous
13
2022
285
0.680
Why?
Cell- and Tissue-Based Therapy
2
2021
170
0.670
Why?
Transplantation, Homologous
20
2024
693
0.620
Why?
Herpesvirus 4, Human
11
2018
676
0.560
Why?
Immunosuppressive Agents
4
2014
690
0.540
Why?
Bone Marrow Transplantation
5
2014
621
0.530
Why?
Transplantation Conditioning
9
2022
299
0.530
Why?
T-Lymphocytes, Cytotoxic
8
2013
522
0.510
Why?
Immunotherapy, Adoptive
7
2018
871
0.450
Why?
Alemtuzumab
7
2024
88
0.450
Why?
Skin Ulcer
1
2014
33
0.440
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
2013
808
0.440
Why?
Thalidomide
1
2014
40
0.440
Why?
Lymphoma, T-Cell
2
2018
65
0.400
Why?
Middle Aged
42
2024
29299
0.390
Why?
Multiple Myeloma
3
2021
199
0.380
Why?
Granulocyte Colony-Stimulating Factor
5
2013
93
0.380
Why?
Herpesvirus 6, Human
3
2017
55
0.370
Why?
Antibodies, Monoclonal
6
2008
1069
0.350
Why?
Lymphoma, Large B-Cell, Diffuse
3
2016
147
0.350
Why?
Adult
40
2024
31881
0.340
Why?
Roseolovirus Infections
2
2007
30
0.340
Why?
Stem Cell Transplantation
4
2006
250
0.330
Why?
Antigens, CD19
6
2018
181
0.320
Why?
Antilymphocyte Serum
3
2006
57
0.310
Why?
Interleukin-2
4
2014
250
0.300
Why?
Neoplasm Recurrence, Local
5
2022
1308
0.300
Why?
Burkitt Lymphoma
2
2006
142
0.290
Why?
Gout
1
2011
167
0.290
Why?
CD40 Ligand
4
2011
65
0.290
Why?
Aged
25
2024
21664
0.290
Why?
Leukemia
3
2022
378
0.290
Why?
Male
51
2024
65713
0.280
Why?
Lymphoma, Follicular
1
2007
29
0.280
Why?
Hematopoietic Stem Cell Mobilization
3
2013
26
0.270
Why?
Paramyxoviridae Infections
1
2007
49
0.270
Why?
Metapneumovirus
1
2007
52
0.270
Why?
Lymphoma, Non-Hodgkin
3
2018
168
0.270
Why?
Paresis
1
2006
33
0.270
Why?
Cancer Vaccines
4
2011
190
0.260
Why?
Rituximab
3
2022
164
0.260
Why?
Hemoglobin SC Disease
1
2006
11
0.260
Why?
Humans
68
2024
133455
0.260
Why?
Viral Matrix Proteins
5
2018
110
0.260
Why?
Leukemia, Myeloid
1
2006
82
0.250
Why?
Receptors, Antigen, T-Cell
3
2020
498
0.250
Why?
Cytomegalovirus Infections
2
2024
228
0.250
Why?
Cytokines
1
2011
1395
0.240
Why?
Antibodies, Neoplasm
5
2008
60
0.240
Why?
Hematologic Neoplasms
5
2021
295
0.240
Why?
Female
46
2024
71472
0.230
Why?
Young Adult
11
2022
9881
0.230
Why?
Antiviral Agents
2
2024
820
0.220
Why?
Lymphoma, B-Cell
3
2018
150
0.220
Why?
Quinazolines
1
2024
183
0.210
Why?
Genetic Therapy
3
2018
728
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
1352
0.210
Why?
Tissue Donors
6
2021
523
0.210
Why?
Recurrence
10
2022
1467
0.200
Why?
Autoimmune Diseases
2
2018
278
0.200
Why?
Adolescent
17
2022
20498
0.200
Why?
Lymphocyte Transfusion
2
2021
58
0.200
Why?
Treatment Outcome
19
2018
12987
0.190
Why?
Carmustine
1
2022
25
0.190
Why?
Neomycin
2
2000
37
0.190
Why?
Melphalan
1
2022
45
0.190
Why?
Graft vs Leukemia Effect
2
2021
36
0.190
Why?
Bone Marrow
2
2021
334
0.190
Why?
Cytarabine
1
2022
100
0.190
Why?
Seizures
1
2006
890
0.180
Why?
Leukemia, Myeloid, Acute
3
2021
568
0.170
Why?
Myelodysplastic Syndromes
1
2021
129
0.160
Why?
Bone Marrow Cells
1
2021
272
0.160
Why?
Tumor Escape
2
2018
65
0.150
Why?
Photosensitivity Disorders
1
2018
11
0.150
Why?
Lymphocyte Depletion
3
2024
125
0.150
Why?
Voriconazole
1
2018
35
0.150
Why?
Antigens, CD
4
2011
452
0.140
Why?
Acute Disease
4
2011
1185
0.140
Why?
Granulomatous Disease, Chronic
1
2018
69
0.140
Why?
Antipyrine
2
1988
4
0.140
Why?
DNA Virus Infections
1
2017
22
0.140
Why?
Diltiazem
2
1988
14
0.140
Why?
DNA Viruses
1
2017
33
0.140
Why?
Epstein-Barr Virus Infections
2
2018
295
0.140
Why?
Peripheral Blood Stem Cell Transplantation
2
2006
34
0.130
Why?
Immunoglobulin kappa-Chains
1
2016
29
0.130
Why?
Genetic Markers
1
1998
631
0.130
Why?
Child
16
2022
25700
0.130
Why?
Retrospective Studies
10
2024
17413
0.120
Why?
Prognosis
4
2021
5058
0.120
Why?
Vidarabine
3
2010
78
0.110
Why?
Diagnostic Imaging
1
2016
308
0.110
Why?
Leukapheresis
1
2013
14
0.110
Why?
Blood Donors
1
2013
62
0.100
Why?
Viruses
1
2014
125
0.100
Why?
Lung Diseases
2
2009
399
0.100
Why?
Remission Induction
5
2016
308
0.100
Why?
Time Factors
7
2018
6578
0.100
Why?
Combined Modality Therapy
4
2021
1307
0.100
Why?
Azoles
1
2012
8
0.100
Why?
Cushing Syndrome
1
2012
22
0.100
Why?
Budesonide
1
2012
21
0.100
Why?
Gene Transfer Techniques
2
2011
364
0.100
Why?
Colchicine
1
2011
39
0.090
Why?
T-Lymphocytes, Regulatory
1
2014
247
0.090
Why?
Immunophenotyping
4
2016
342
0.090
Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
63
0.090
Why?
Quality of Life
1
2021
2125
0.090
Why?
Virus Diseases
1
2014
288
0.090
Why?
Cytomegalovirus
3
2024
271
0.090
Why?
CD28 Antigens
1
2011
81
0.090
Why?
Retroviridae
3
2016
198
0.090
Why?
Allopurinol
1
2011
75
0.090
Why?
Primary Myelofibrosis
1
2011
50
0.090
Why?
Hematopoietic Stem Cells
2
2013
563
0.090
Why?
B-Lymphocytes
1
2013
549
0.080
Why?
Steroids
1
2011
210
0.080
Why?
Transplantation Chimera
2
2008
42
0.080
Why?
Lymphocyte Subsets
1
2009
41
0.080
Why?
Follow-Up Studies
5
2018
5487
0.080
Why?
Cell Proliferation
5
2018
2536
0.080
Why?
Anti-Inflammatory Agents
1
2012
319
0.080
Why?
Histocompatibility
2
2006
50
0.080
Why?
DNA, Viral
2
2007
498
0.080
Why?
Neoplasm Staging
2
2016
1388
0.080
Why?
Adenoviridae
4
2013
609
0.080
Why?
Theophylline
1
1988
30
0.070
Why?
Verapamil
1
1988
58
0.070
Why?
Virus Integration
1
2007
40
0.070
Why?
Antigens, CD34
1
2007
112
0.070
Why?
Lymphocyte Activation
3
2018
724
0.070
Why?
Encephalitis, Viral
1
2007
21
0.070
Why?
Positron Emission Tomography Computed Tomography
2
2018
80
0.070
Why?
Minoxidil
1
1986
4
0.070
Why?
Antigen-Presenting Cells
1
2007
133
0.070
Why?
Body Mass Index
1
2013
1707
0.070
Why?
Exchange Transfusion, Whole Blood
1
2006
13
0.070
Why?
Filgrastim
1
2006
13
0.070
Why?
Survival Analysis
4
2016
1596
0.060
Why?
Anti-Bacterial Agents
1
1998
2513
0.060
Why?
CD4-Positive T-Lymphocytes
2
2006
506
0.060
Why?
Anemia, Aplastic
1
2006
62
0.060
Why?
Feasibility Studies
3
2016
817
0.060
Why?
Benzazepines
1
1986
61
0.060
Why?
Amyotrophic Lateral Sclerosis
1
2008
190
0.060
Why?
Immune System Diseases
1
2006
50
0.060
Why?
Major Histocompatibility Complex
1
2006
57
0.060
Why?
Leukemia, B-Cell
1
2005
26
0.060
Why?
Lymphocyte Count
3
2014
125
0.060
Why?
Antibodies, Monoclonal, Humanized
5
2008
553
0.060
Why?
Cell Culture Techniques
1
2006
292
0.060
Why?
Disease-Free Survival
3
2013
969
0.060
Why?
Leukocyte Common Antigens
1
2005
93
0.060
Why?
Antineoplastic Agents
3
2013
1846
0.060
Why?
Graft Rejection
1
2008
624
0.060
Why?
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
1
2004
15
0.060
Why?
Acetates
1
2024
79
0.060
Why?
Myelin Basic Protein
1
2004
69
0.050
Why?
Drug Interactions
3
2012
261
0.050
Why?
CD8-Positive T-Lymphocytes
1
2006
442
0.050
Why?
Drug Resistance, Neoplasm
3
2010
820
0.050
Why?
Herpesviridae Infections
1
2004
147
0.050
Why?
Autoantigens
1
2004
118
0.050
Why?
Phosphoproteins
1
2006
453
0.050
Why?
Recovery of Function
1
2005
473
0.050
Why?
Cell Line
3
2013
2834
0.050
Why?
Glycoproteins
1
2005
380
0.050
Why?
Child, Preschool
7
2018
14758
0.050
Why?
Recombinant Proteins
1
2006
1439
0.050
Why?
Genetic Vectors
2
2013
968
0.050
Why?
Positron-Emission Tomography
2
2016
304
0.050
Why?
Lymphoma, AIDS-Related
1
2002
39
0.050
Why?
Lymphocytes
1
2023
440
0.050
Why?
T-Cell Antigen Receptor Specificity
1
2021
57
0.050
Why?
Graft Survival
3
2011
557
0.040
Why?
Antibodies, Viral
1
2007
1204
0.040
Why?
Demography
1
2021
247
0.040
Why?
Allografts
1
2021
196
0.040
Why?
Multiple Sclerosis
1
2004
390
0.040
Why?
CD5 Antigens
2
2010
36
0.040
Why?
Nuclear Proteins
1
2006
1334
0.040
Why?
Liver
1
1986
1850
0.040
Why?
Anti-HIV Agents
1
2002
345
0.040
Why?
Chimerism
1
2018
29
0.040
Why?
Philadelphia Chromosome
1
1998
43
0.040
Why?
Guillain-Barre Syndrome
1
2018
31
0.040
Why?
Pancytopenia
1
2018
42
0.040
Why?
Genes, Viral
1
1998
186
0.040
Why?
Injections, Intravenous
1
1998
254
0.040
Why?
Unrelated Donors
1
2018
70
0.040
Why?
Drug Resistance, Microbial
1
1998
194
0.040
Why?
Red-Cell Aplasia, Pure
1
1997
3
0.040
Why?
Sarcoidosis
1
1998
62
0.040
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1998
100
0.040
Why?
Kaplan-Meier Estimate
2
2013
1135
0.030
Why?
Mitosporic Fungi
1
1997
9
0.030
Why?
Erythropoiesis
1
1997
43
0.030
Why?
Adenoviruses, Human
1
2017
99
0.030
Why?
Cells, Cultured
2
2018
3162
0.030
Why?
Administration, Oral
2
2012
727
0.030
Why?
BK Virus
1
2017
61
0.030
Why?
Skin Diseases
1
1998
135
0.030
Why?
Interferon-alpha
1
1998
248
0.030
Why?
Whole-Body Irradiation
2
2006
61
0.030
Why?
Mycoses
1
1997
121
0.030
Why?
Antifungal Agents
1
2018
309
0.030
Why?
Tomography, X-Ray Computed
2
2016
2190
0.030
Why?
Workflow
1
2016
133
0.030
Why?
Prospective Studies
3
2014
6649
0.030
Why?
Adoptive Transfer
1
2016
241
0.030
Why?
Phenotype
2
2018
4525
0.030
Why?
Kinetics
2
1986
1350
0.030
Why?
Postoperative Care
1
2016
308
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2016
866
0.030
Why?
Monitoring, Physiologic
1
2016
387
0.030
Why?
Species Specificity
1
2014
571
0.030
Why?
Blood Cell Count
1
2013
70
0.030
Why?
Protein Engineering
1
2013
73
0.030
Why?
Hepatitis C
1
1997
387
0.030
Why?
Tumor Microenvironment
1
2018
680
0.030
Why?
Etoposide
1
2013
120
0.030
Why?
Transduction, Genetic
1
2013
296
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2007
1326
0.030
Why?
Cell Separation
1
2013
234
0.020
Why?
South America
1
2012
42
0.020
Why?
Cross-Sectional Studies
1
2021
3738
0.020
Why?
Immunotherapy
2
2011
744
0.020
Why?
North America
1
2012
260
0.020
Why?
Flow Cytometry
1
2014
836
0.020
Why?
Iatrogenic Disease
1
2012
136
0.020
Why?
Cyclophosphamide
1
2013
417
0.020
Why?
Epidemiologic Methods
1
2011
110
0.020
Why?
Infant
3
2014
13118
0.020
Why?
Cell Adhesion
1
2011
363
0.020
Why?
Incidence
1
2018
3385
0.020
Why?
Plasmids
1
2011
525
0.020
Why?
Dose-Response Relationship, Drug
1
2014
1731
0.020
Why?
Hyaluronan Receptors
1
2010
68
0.020
Why?
Risk Factors
3
2013
11054
0.020
Why?
Bronchoalveolar Lavage Fluid
1
2009
157
0.020
Why?
Extracellular Matrix Proteins
1
2010
161
0.020
Why?
Protein Structure, Tertiary
1
2011
783
0.020
Why?
Stem Cells
1
2014
751
0.020
Why?
Biopsy, Fine-Needle
1
2009
123
0.020
Why?
Immunity
1
2009
188
0.020
Why?
Medical Records
1
2009
194
0.020
Why?
Gene Expression
1
2013
1614
0.020
Why?
ATP-Binding Cassette Transporters
1
2010
197
0.020
Why?
Cytochrome P-450 Enzyme Inhibitors
1
1988
4
0.020
Why?
Immunization
1
2010
315
0.020
Why?
Metabolic Clearance Rate
1
1988
145
0.020
Why?
Severe Combined Immunodeficiency
1
2008
108
0.020
Why?
Longitudinal Studies
1
2012
1486
0.020
Why?
Living Donors
1
2008
118
0.020
Why?
Gastrointestinal Diseases
1
2012
360
0.020
Why?
Half-Life
1
1988
160
0.020
Why?
Cerebrospinal Fluid Proteins
1
2007
22
0.020
Why?
Radiography
1
2009
825
0.020
Why?
Metabolic Diseases
1
2008
138
0.020
Why?
Chemistry
1
1986
61
0.020
Why?
Electrochemistry
1
1986
25
0.020
Why?
Chemical Phenomena
1
1986
88
0.020
Why?
Drug Stability
1
1986
62
0.020
Why?
Respiratory Tract Infections
1
2009
293
0.020
Why?
Tacrolimus
1
2006
105
0.020
Why?
Cyclosporine
1
2006
148
0.020
Why?
B7-2 Antigen
1
2005
16
0.020
Why?
Receptors, Interleukin-2
1
2005
44
0.020
Why?
Pneumonia
1
2009
342
0.020
Why?
Siblings
1
2006
198
0.020
Why?
CD52 Antigen
1
2005
7
0.020
Why?
Biopsy
1
2009
1301
0.020
Why?
United States
1
2021
11645
0.020
Why?
T-Lymphocytes, Helper-Inducer
1
2005
83
0.020
Why?
T-Lymphocyte Subsets
1
2006
215
0.020
Why?
Chromatography, High Pressure Liquid
1
1986
363
0.020
Why?
CD3 Complex
1
2005
93
0.010
Why?
Neoplasm Proteins
1
2010
716
0.010
Why?
Virus Activation
1
2005
85
0.010
Why?
Coculture Techniques
1
2005
246
0.010
Why?
Texas
1
2013
3681
0.010
Why?
Immune System
1
2005
98
0.010
Why?
Histocompatibility Testing
1
2005
150
0.010
Why?
Area Under Curve
1
2005
331
0.010
Why?
Methotrexate
1
2006
355
0.010
Why?
Genes, Immunoglobulin
1
2004
34
0.010
Why?
Age Distribution
1
2005
444
0.010
Why?
Immunoglobulin Variable Region
1
2004
52
0.010
Why?
Age Factors
1
2011
2978
0.010
Why?
Pilot Projects
1
2008
1488
0.010
Why?
Thymus Gland
1
2004
105
0.010
Why?
Platelet Transfusion
1
2004
54
0.010
Why?
Antigens, Viral
1
2005
440
0.010
Why?
Predictive Value of Tests
1
2009
2302
0.010
Why?
Cell Differentiation
1
2011
2024
0.010
Why?
Survival Rate
1
2008
2199
0.010
Why?
Polymerase Chain Reaction
1
2007
1632
0.010
Why?
Radiography, Thoracic
1
2004
152
0.010
Why?
Forkhead Transcription Factors
1
2005
382
0.010
Why?
Viral Load
1
2004
411
0.010
Why?
Interleukin-10
1
2004
191
0.010
Why?
Cell Division
1
2004
773
0.010
Why?
Antibodies
1
2004
382
0.010
Why?
Horses
1
2001
103
0.010
Why?
Interferon-gamma
1
2004
538
0.010
Why?
Tumor Necrosis Factor-alpha
1
2004
707
0.010
Why?
Drug Resistance
1
2001
263
0.010
Why?
Cell Movement
1
2004
916
0.010
Why?
Rabbits
1
2001
735
0.010
Why?
Drug Administration Schedule
1
2001
753
0.010
Why?
Data Collection
1
2001
397
0.010
Why?
Aged, 80 and over
1
2011
7183
0.010
Why?
Adrenal Cortex Hormones
1
2001
339
0.010
Why?
Lung Neoplasms
1
2009
1791
0.010
Why?
Cell Line, Tumor
1
2005
3725
0.010
Why?
Erythroid Precursor Cells
1
1997
24
0.010
Why?
Aspergillus fumigatus
1
1997
44
0.010
Why?
Global Health
1
2001
619
0.010
Why?
Practice Guidelines as Topic
1
2001
1329
0.010
Why?
Postoperative Complications
1
2006
3208
0.010
Why?
HIV Infections
1
2002
2059
0.000
Why?
Animals
1
2001
36278
0.000
Why?
CARRUM's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (331)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_